April 15th - 17th, 2019, Philadelphia, Pennsylvania (USA)

World Drug Safety Congress Americas 2019

The World Drug Safety Congress Americas for over 10 years has served as the only commercially focused event for the pharmacovigilance community. In 2018, we were proud to be the only event to gather over 30 Global Heads of PV from the leading pharmaceutical companies including Merck, Novartis, Roche, Pfizer, Astellas, Boehringer Ingelheim, CSL Behring, Alnylam, Shire, Kite-Gilead, AstraZeneca, Moderna, Zogenix, Intarcia, GlaxoSmithKline, Quark, Portola, Celgene, Keyrus, Taimei, Fibrogen and Genzyme.

 

23rd - 25th January 2019, Basel, Switzerland

R&D Data Intelligence Leaders Forum 2019

The “R&D Data Intelligence Leaders Forum” is the must attend event for those senior decision-makers, researchers and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D decision-making and intelligence.

 

 

 

21st - 23rd November 2018, London, UK

Real World Evidence & Advanced Data Strategy

This conference will facilitate dialogue and exchanges among stakeholders about the real application, impact and opportunity in incorporating RWE in all stage of the drug and product strategy, exploring unmet needs, precision medicine and new opportunities to meet patient’s needs.

Integrating the complexity of information about patients in the medical product development is one of the challenges that the pharmaceutical industry needs to take.The increase in the generation and use of Real World Evidence and Big Data in health product provides a great opportunity for both pharma and patients to determine more effective treatments and evaluation of therapeutics.